Nordic Walking for Individuals With Osteoporosis, Vertebral Fracture or Hyperkyphosis
1 other identifier
interventional
117
1 country
1
Brief Summary
Nordic walking is currently offered by a number of health care practitioners as a form of exercise therapy for older adults at risk of fracture. These include older individuals with osteoporosis, previous vertebral fracture, or hyperkyphosis. To the investigators knowledge, this practice is not evidence-based and thus potentially problematic as benefits and safety of Nordic walking for individuals with osteoporosis, fractures, or hyperkyphosis are unknown. The proposed study will answer the following principal question: Does Nordic walking improve mobility, physical function, posture, and quality of life for ambulant community dwelling individuals who have osteoporosis, a history of osteoporotic fracture, or hyperkyphosis? Participants will be randomized into either the Nordic walking intervention group, or the waiting-list control group. Participants will initially train 3 times per week for 3 months, led by peer- and/or student-instructors. The Nordic walking training will depend on the participant's skill and comfort level and will consist of walking with poles over a distance set individually for each participant. The control group will receive the same 3-month Nordic walking intervention after their control follow-up measurements are completed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 21, 2019
CompletedFirst Posted
Study publicly available on registry
March 21, 2019
CompletedStudy Start
First participant enrolled
October 18, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 21, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 21, 2023
CompletedFebruary 7, 2024
February 1, 2024
4.2 years
February 21, 2019
February 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Functional balance
Assessed by timed up and go test (TUG)
3-5 minutes
Quality of life score
Assessed by 36-Item Short Form Survey (SF-36). Survey consists of 36 questions with 8 sub-scales: Physical functioning, role limitations due to physical health, role limitations due to emotional problems, energy/fatigue, emotional well-being, social functioning, pain, and general health. Responses range from 1-6 and are scored according to a key that values each answer from 0-100, where higher values are better outcomes. The average score of each sub-scale is recorded.
5-10 minutes
Kyphosis angle
Assessed using kyphometer
2-3 minutes
Secondary Outcomes (9)
Muscle strength
2-4 minutes
Mobility
16-20 minutes
Bone and muscle properties and estimated bone strength of the lower leg and forearm
20-30 minutes
Total body lean tissue mass (g)
10-20 minutes
Proximal femur bone mineral density (g/cm^2)
10-20 minutes
- +4 more secondary outcomes
Study Arms (2)
Nordic walking
EXPERIMENTALNordic walking exercise intervention, 3 times per week over 12 weeks
Control
NO INTERVENTIONWaiting list controls will be offered same Nordic walking intervention after 3 month follow-up measurements
Interventions
Participants will initially train 3 times per week for 3 months. Training sessions will be led by trained peer- and/or student-instructors. Nordic walking sessions (starting at 20 and progressing to 60min/session) will include a warm-up, strengthening, and dynamic balance and stretching exercises in addition to Nordic walking, as per the Saskatoon Health Region guide (Saskatoon Health Region, 2014). Training (distance and intensity) will be progressive and individually set.
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- University of Saskatchewanlead
- Royal University Hospital Foundationcollaborator
- Saskatchewan Health Research Foundationcollaborator
- Saskatchewan Centre for Patient-Oriented Researchcollaborator
Study Sites (1)
University of Saskatchewan
Saskatoon, Saskatchewan, S7N 5B2, Canada
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Saija Kontulainen, PhD
University of Saskatchewan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Research assistants and technicians collecting data will be blinded as to whether participants are in the exercise or control group. Participants will not be blinded for Nordic walking. All methods and reporting of the trial will follow Consolidated Standards of Reporting Trials (CONSORT) guidelines.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 21, 2019
First Posted
March 21, 2019
Study Start
October 18, 2019
Primary Completion
December 21, 2023
Study Completion
December 21, 2023
Last Updated
February 7, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share